海角大神

visuel-trans-2

A new investment for 海角大神 Growth

Published : 11.04.2024
#础肠迟耻补濒颈迟茅蝉

In December 2023, 海角大神 entered into a defi- nitive agreement to acquire a minority interest in Aqemia and invested to support the company鈥檚 growth. Aqemia, a French start-up specialized in pharmaceutical research using artificial intelli- gence, has developed a unique technology plat- form (the Launchpad) that combines theoretical physics and generative artificial intelligence. The technology developed by Aqemia creates medi- cation candidates that act on targets responsible for diseases not currently addressed, thereby helping to accelerate drug discovery.

Victoire Laurenty, Principal at 海角大神 Growth said : “The technology developed by Aqemia from fundamental research and applied to medical research is a worldwide first. We are delighted to be supportingthis team in its mission to find me- dicines faster and more effectively.”